Awareness campaign at World COPD Day

C. Pacheco, J. F. Cruz, C. Lacerda, L. Ferreira, J. Cunha (Braga, Portugal)

Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Session: Diagnosis and management of respiratory diseases
Session type: Thematic Poster Session
Number: 4171
Disease area: Airway diseases

Congress or journal article abstractE-poster

Abstract

Introduction: Chronic Obstructive Pulmonary Disease (COPD) is a major cause of chronic morbidity, affecting 14% of the Portuguese population. The World COPD Day was on November 14th, 2012. At Hospital de Braga was held an awareness campaign.
Objective: To characterize epidemiological, clinical and functional participants in the campaign of World COPD Day.
Methods: Cross-sectional study with a questionnaire and spirometry to all individuals participating in the campaign.
Results: 160 subjects were included, 51% male, mean age 56 years. A significant part of the population (44.3%) attended 4 years of school and had a history of smoking habits (44,3%). The body mass index was 26.9 kg/m2. A quarter of the participants had a history of respiratory disease (asthma and chronic bronchitis were the main entities). When asked about if they know COPD and its methods of diagnosis, 62.5% of the population claimed to have no knowledge of this disease and only 29.4% knew what a spirometry was. Twenty-five subjects had previously performed a spirometry. We found that 3 spirometry were not likely to be reported because they did not meet acceptability and reproducibility criteria. Sixteen individuals (10.2%) presented with obstructive ventilatory changes, ten of which with respiratory history. In this group the average FEV1 was 77%, FVC 98% and FEV1/FVC ratio of 64. Two participants in this group had an obstruction considered severe.
Conclusion: The aim of these campaigns is to raise awareness and inform the population about diseases often ignored despite their prevalence. It’s also important to diagnose, treat and possible monitor some individuals who didn’t kow they had a problem.
In our population there was a prevalence of obstructive respiratory disease of 10.2%.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Pacheco, J. F. Cruz, C. Lacerda, L. Ferreira, J. Cunha (Braga, Portugal). Awareness campaign at World COPD Day. Eur Respir J 2013; 42: Suppl. 57, 4171

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Awareness campaigns on the WORLD COPD Day
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Obstructive diseases - Epidemiology and public awareness of the causes, course and effects. Selected results of the Polish Spirometry Day 2013 and World Spirometry Day 2014
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015


Influence of smoking on respiratory function and status of proteinas-inhibitory system in patients COPD
Source: International Congress 2014 – Passive smoking, active smoking and COPD
Year: 2014


Polish and World spirometry days – Three years of research experience on causes and consequences of obstructive diseases in Poland
Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing
Year: 2016


Patients recall of an educational programme
Source: International Congress 2014 – Smoking cessation
Year: 2014


Assessment of asthma in firefighter applicants
Source: International Congress 2016 – Occupational epidemiology
Year: 2016


Lung cancer screening in COPD patients: NLST criteria vs a COPD screening score
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


How to enhance social knowledge on respiratory diseases? Polish Spirometry Day 2011 and 2013, World Spirometry Day 2012
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013


The 2013 updated GOLD strategy: A comparison of the various scenarios
Source: International Congress 2014 – Best abstracts in chronic care
Year: 2014

Feasibility of lung cancer screening in a population of patients with emphysema and/or COPD meeting NLST criteria
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015

Activities during the World Asthma Day in 2012: Its utility for detecting underdiagnosis and undertreatment in asthma patients
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013

Romanian awareness and screenings for Obstructive Airway disease - World  Asthma and COPD Day 2017
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018


Implementation of COPD phenotypes in real life
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Paediatric exercise testing: Who goes the distance?
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014


Diagnostic sensitivity of a symptom-based questionnaire, the Canadian Lung Health Test (CLHT), in subjects at risk for COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 514s
Year: 2005

Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014


COPD classification according GOLD 2013 and Latin American Thoracic Association (ALAT) recommendations in PUMA study
Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing
Year: 2016

COPD prevalence in Argentina: The EPOC.AR study
Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing
Year: 2016

The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014


The implementation of GOLD 2011 among pulmonary specialists in the Czech Republic
Source: International Congress 2014 – Management of COPD in primary care
Year: 2014